Under construction – not a live service
Sign in
Taking peopleNo phase

Registry Following Adults with Malignant Hypertension Across Several Centers

Builds a database of adults with malignant hypertension to study the disease over time.

Plain-language title generated from the registry record
Registry title: A New Breath for Malignant Hypertension: Implementation of the HAMA Cohort

Key facts

Where
Warsaw, PolandSee the site

Where in Poland

  • National Institute of CardiologyWarsaw, PolandNot yet recruiting

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Centre Hospitalier de PAU
Trial code
NCT03755726
Record updated
23 March 2026
Original description
This registry aims to provide the first prospective, multicentric database of patients with malignant hypertension. It will allow to assess modern epidemiology of the disease, diversity of current management and care pathway, to deepen our pathophysiological knowledges, to modernize the definition of this form of hypertension and its diagnostic criteria. The network that will emerge will finally lead to the opportunity of setting up therapeutic trials and establishing recommendations based on solid scientific evidence.Read full original descriptionShow less

A New Breath for Malignant Hypertension: Implementation of the HAMA Cohort

This registry aims to provide the first prospective, multicentric database of patients with malignant hypertension. It will allow to assess modern epidemiology of the disease, diversity of current management and care pathway, to deepen our pathophysiological knowledges, to modernize the definition of this form of hypertension and its diagnostic criteria. The network that will emerge will finally lead to the opportunity of setting up therapeutic trials and establishing recommendations based on solid scientific evidence.

Inclusion: Malignant hypertension according to the classic definition (Severe hypertension, above 180/110 associated with severe hypertensive retinopathy); Severe hypertension (above 180/110) associated with acute damage of 3 target organ due to high blood pressure.

Exclusion: Age < 18 years old; Patients who cannot freely give their consent, or patients who refuse to participate; Dialysis.

ClinicalTrials.gov NCT03755726